Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 4, 2007
Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritisSergio Mezzano, Alejandra Droguett, M Eugenia Burgos, et al.
Revista Medica De Chile|March 2, 2016
[A consensus of the Chilean Nephrology and Rheumatology Societies on renal involvement in systemic lupus erythematosus]Verónica Aguirre, Miriam Alvo, Leopoldo Ardiles, et al.
Gastroenterologia Y Hepatologia|November 30, 2024
Spanish Working Group in Crohn's Disease and Ulcerative Colitis (GETECCU) position paper on cardiovascular disease in patients with inflammatory bowel diseaseIgnacio Marín-Jiménez, Daniel Carpio, Vicent Hernández, et al.
Plos One|July 19, 2014
Tubular overexpression of gremlin induces renal damage susceptibility in miceAlejandra Droguett, Paola Krall, M Eugenia Burgos, et al.
Kidney International. Supplement|September 13, 2003
Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathySergio A Mezzano, Claudio A Aros, Alejandra Droguett, et al.
International Journal of Molecular Sciences|June 18, 2020
Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic NephropathyLucas Opazo-Ríos, Anita Plaza, Yenniffer Sánchez Matus, et al.
Revista Espanola De Salud Publica|June 17, 2020
[Effectiveness of the contingency plan of the internal inflammatory disease unit before Covid-19 infection.]Daniel Carpio López, Modesto Martínez Pillado, Ángel Salgado Barreira, et al.
Journal of Cellular Biochemistry|October 13, 2012
Altered expression and localization of insulin receptor in proximal tubule cells from human and rat diabetic kidneyRodrigo Gatica, Romina Bertinat, Pamela Silva, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|October 1, 2011
A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving AzathioprineWilliam Zabala-Fernández, Manuel Barreiro-de Acosta, Ana Echarri, et al.
Revista Espanola De Enfermedades Digestivas|September 29, 2025
Effectiveness and safety of dual advanced therapy in inflammatory bowel disease ‒ A multicenter series from Galicia, SpainM ª Teresa Diz-Lois Palomares, Carmen Pradera Cibreiro, Carmen Cabezal Iglesias, et al.
Pageof 8